TM9SF1 expression based on
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Comparison Statistical significance Normal-vs-Primary 3.857600E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Cancer stage information is not available for 3 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Stage1
7.290600E-01
Normal-vs-Stage2
3.626400E-01
Normal-vs-Stage3
7.526600E-01
Normal-vs-Stage4
4.761200E-01
Stage1-vs-Stage2
5.646600E-01
Stage1-vs-Stage3
3.432600E-01
Stage1-vs-Stage4
4.516400E-01
Stage2-vs-Stage3
9.441900E-02
Stage2-vs-Stage4
4.741800E-01
Stage3-vs-Stage4
2.171000E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient race information is not available for 5 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Caucasian
3.997200E-01
Normal-vs-AfricanAmerican
4.967200E-01
Normal-vs-Asian
6.744400E-01
Caucasian-vs-AfricanAmerican
8.389600E-01
Caucasian-vs-Asian
5.542800E-01
AfricanAmerican-vs-Asian
6.041600E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient gender information is not available for 1 sample.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Male
4.085200E-01
Normal-vs-Female
3.823800E-01
Male-vs-Female
8.636600E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient age information is not available for 1 sample.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Age(21-40Yrs)
6.681000E-01
Normal-vs-Age(41-60Yrs)
1.358820E-01
Normal-vs-Age(61-80Yrs)
6.003400E-01
Normal-vs-Age(81-100Yrs)
6.434600E-01
Age(21-40Yrs)-vs-Age(41-60Yrs)
4.259800E-01
Age(21-40Yrs)-vs-Age(61-80Yrs)
8.456400E-01
Age(21-40Yrs)-vs-Age(81-100Yrs)
9.147200E-01
Age(41-60Yrs)-vs-Age(61-80Yrs)
7.225600E-04
Age(41-60Yrs)-vs-Age(81-100Yrs)
1.638960E-01
Age(61-80Yrs)-vs-Age(81-100Yrs)
5.974400E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Drinking status is not available for 80 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Non Drinker
7.575200E-01
Normal-vs-Daily Drinker
6.092800E-01
Normal-vs-Weekly Drinker
7.980600E-01
Normal-vs-Occasional Drinker
1.506360E-01
Normal-vs-Social Drinker
4.535400E-01
Non Drinker-vs-Daily Drinker
4.764200E-01
Non Drinker-vs-Weekly Drinker
9.790800E-01
Non Drinker-vs-Occasional Drinker
3.403800E-03
Non Drinker-vs-Social Drinker
2.179400E-01
Daily Drinker-vs-Weekly Drinker
5.669400E-01
Daily Drinker-vs-Occasional Drinker
6.180400E-02
Daily Drinker-vs-Social Drinker
6.502400E-01
Weekly Drinker-vs-Occasional Drinker
1.894290E-02
Weekly Drinker-vs-Social Drinker
3.105800E-01
Occasional Drinker-vs-Social Drinker
1.807970E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma
Subtype descriptions Grade 1 Well differentiated (low grade)
Grade 2 Moderately differentiated (intermediate grade) Grade 3 Poorly differentiated (high grade)
Grade 4 Undifferentiated (high grade)
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Grade 1
3.640400E-01
Normal-vs-Grade 2
7.377200E-01
Normal-vs-Grade 3
6.609400E-01
Normal-vs-Grade 4
1.000000E+00
Grade 1-vs-Grade 2
3.363600E-01
Grade 1-vs-Grade 3
9.769200E-01
Grade 1-vs-Grade 4
3.640400E-01
Grade 2-vs-Grade 3
6.995900E-02
Grade 2-vs-Grade 4
7.377200E-01
Grade 3-vs-Grade 4
6.609400E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Diabetes status information is not available for 30 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Diabetic
6.836400E-01
Normal-vs-NonDiabetic
3.580000E-01
Diabetic-vs-NonDiabetic
1.117390E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Pancreatitis status is not available for 39 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Pancreatitis
9.906400E-01
Normal-vs-NoPancreatitis
3.901600E-01
Pancreatitis-vs-NoPancreatitis
9.340400E-02
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Nodal metastais status is not available for 1 sample and cancer in nearby lymph nodes cannot be measured (NX) in 4 samples.
pathologic_N descriptions N0 No regional lymph node metastasis
N1 Metastases in 1 to 3 axillary lymph nodes N2 Metastases in 4 to 9 axillary lymph nodes
N3 Metastases in 10 or more axillary lymph nodes
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-N0
5.732400E-01
Normal-vs-N1
3.347400E-01
N0-vs-N1
2.340000E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Whole exome sequencing data is not available for 3 samples.
TP53 mutation status is obtained from TCGA whole exome sequencing data. We downloaded Mutation Annotation Format (MAF) files (derived from VarScan2) from Genomic Data Commons portal. The sample with/without TP53 mutation were matched with RNA-seq data
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-TP53-Mutant
2.154200E-01
Normal-vs-TP53-NonMutant
5.124600E-01
TP53-Mutant-vs-TP53-NonMutant
1.401990E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
